Search results
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 9 hours agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
Will your last COVID vaccine work against new ‘FLiRT’ variants?
WJZY via Yahoo News· 4 days ago(NEXSTAR) — There are two new COVID-19 variants circulating, posing a threat to a summer surge. The...
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 1 day agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Jacob Rees-Mogg claims UK government 'downplayed' risks of AstraZeneca COVID vaccine
Yahoo News UK· 6 days agoIn the first year, vaccinations were estimated to have prevented 19.8 million COVID-19 deaths...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 5 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 6 days agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 6 days agoNovavax logo and COVID-19 virus images photographed off Apple devices. (STRF/STAR ...2023, is not so...
There might be stockpiles, but making an effective bird flu vaccine won’t be quick or easy
The Telegraph via Yahoo News· 2 days agoHealth officials have been steadfast in their assurances. The risk of H5N1 bird flu jumping into...
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
NewMediaWire via Yahoo Finance· 2 days agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 6 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...